VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 229 filers reported holding VERACYTE INC in Q1 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $52,676 | -12.3% | 2,359 | 0.0% | 0.00% | – |
| Q2 2023 | $60,084 | +127738.3% | 2,359 | +11.3% | 0.00% | – |
| Q1 2023 | $47 | -6.0% | 2,119 | 0.0% | 0.00% | – |
| Q4 2022 | $50 | -99.9% | 2,119 | 0.0% | 0.00% | – |
| Q3 2022 | $42,000 | +2.4% | 2,119 | +2.7% | 0.00% | – |
| Q2 2022 | $41,000 | -37.9% | 2,064 | -13.6% | 0.00% | – |
| Q1 2022 | $66,000 | -10.8% | 2,390 | -1.6% | 0.00% | -100.0% |
| Q4 2021 | $74,000 | -37.3% | 2,430 | -4.7% | 0.00% | 0.0% |
| Q3 2021 | $118,000 | +15.7% | 2,550 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $102,000 | -25.5% | 2,550 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $137,000 | +9.6% | 2,550 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $125,000 | +83.8% | 2,550 | +21.4% | 0.00% | 0.0% |
| Q3 2020 | $68,000 | +385.7% | 2,100 | +281.8% | 0.00% | – |
| Q2 2020 | $14,000 | +7.7% | 550 | 0.0% | 0.00% | – |
| Q1 2020 | $13,000 | – | 550 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 121,880 | $2,718 | 2.56% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 209,653 | $4,675,262 | 1.93% |
| EFG Asset Management (North America) Corp. | 270,772 | $6,032,800 | 1.33% |
| ARK Investment Management | 8,409,106 | $187,523,064 | 1.29% |
| Nikko Asset Management Americas, Inc. | 3,293,645 | $72,130,826 | 0.83% |
| CLOUGH CAPITAL PARTNERS L P | 339,978 | $7,581,509 | 0.82% |
| Granahan Investment Management | 1,145,527 | $25,545,252 | 0.78% |
| OBERWEIS ASSET MANAGEMENT INC/ | 212,180 | $4,731,614 | 0.73% |
| Parkman Healthcare Partners LLC | 118,622 | $2,645,271 | 0.58% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 173,717 | $3,873,889 | 0.56% |